Built for PSX investors
Your market watch, portfolio and news desk in one app.
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.
Built for PSX investors
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.
Liven Pharma Limited corrected two inadvertent errors in its published Annual Report 2026 and Notice of Annual General Meeting. The Statement of Compliance should refer to 2026, not 2025, and the relevant AGM notice heading should say “Annual” rather than “Six Months.” The company states that these corrections do not affect the financial statements, reports, or AGM details.
Liven Pharma Limited will hold its Annual General Meeting on October 26, 2026 at 11:00 a.m. at its registered office in Lahore and through a web-link meeting. The agenda includes approval of the prior AGM minutes, consideration of audited annual financial statements for the year ended June 30, 2026, and appointment of statutory auditors for the year ending June 30, 2027. Share transfer books will remain closed from October 19 through October 26, 2026.
Liven Pharma Limited will hold its Annual General Meeting on Monday, October 26, 2026 at 11:00 a.m. at its registered office in Lahore, with participation also available by video link. The agenda includes approval of the prior AGM minutes, consideration of the six-month audited accounts for the financial year ended June 30, 2026, appointment of auditors for the year ending June 30, 2027, and other business. Share transfer books will be closed from October 19 through October 26, 2026.
Revenue declined year over year, while the company’s net loss and loss per share narrowed substantially. The company also reported higher gross profit and a reduced operating loss.
Liven Pharma Limited has transmitted its Annual Report for the year ended June 30, 2026. The report cover and contents page are visible in the supplied pages; the report lists the company’s website as www.liven-pharma.com.
Liven Pharma Limited informed the Pakistan Stock Exchange that its Board meeting, scheduled for October 2, 2026 at 16:00 in Lahore to consider financial and related matters, was in progress. The board’s decision was expected to be communicated on the next working day before market opening.
A board meeting is scheduled to consider annual accounts and other matters.
This announcement details the sale of shares by the Executive Director of Liven Pharma Limited.
Liven Pharma Ltd (LIVEN) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. Read company disclosures, financial-result notices, corporate actions and meeting updates. Open the relevant notice for its dates and terms.
This page brings together available disclosures for Liven Pharma Ltd (LIVEN), including results, corporate actions, meeting notices and other company updates. Open an individual announcement to read its details and available source document.
Look for the relevant financial-result or corporate-action announcement. Check its reporting period, dividend amount and any conditions in the notice; publication date is not necessarily the payment or entitlement date.
A future date should only be taken from an announcement that explicitly states it. Past payment dates or a historical dividend yield do not establish the next payout or book-closure schedule.
Use the Fundamentals section for available earnings, dividend and valuation figures, keeping each reporting period in view.
LIVEN financial results and fundamentalsPSX guides
What results, payouts, board meetings and other PSX disclosures mean for investors.
A practical PSX company research checklist for beginners: read stock pages, fundamentals, charts, technicals, announcements, annual reports and market news before buying.
Read guide
A plain-English guide to how capital gains tax (CGT) and dividend tax work on Pakistan Stock Exchange shares - filer vs non-filer rates, how holding period and acquisition date matter, how NCCPL collects CGT, and what you still have to declare.
Read guide
A beginner-friendly PSX guide comparing dividend stocks and growth stocks, including risks, investor fit, sectors, interest rates and market cycles.
Read guideData source: Market data is provided under a Pakistan Stock Exchange data license held by Recube Technologies (investify.pk), listed on the official PSX services page. Quotes, charts and derived figures are for information only and may be delayed, adjusted or revised by the exchange.
Not financial advice: Investify is not a brokerage and does not provide investment, trading or financial advice. Nothing on this page is a recommendation to buy or sell any security. Do your own research or consult a licensed advisor before making investment decisions. Read our data & editorial policy.
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.
